Literature DB >> 12146760

Recovery and studies on chlamydospore-negative Candida albicans isolated from clinical specimens.

S S A Al-Hedaithy1, R Fotedar.   

Abstract

During a period of 31 months, we isolated 3525 strains of Candida albicans from different patient specimens. Twenty-five of these (0.71%), obtained from female patients, displayed morphological and biochemical characteristics different from those seen in typical C. albicans. The failure to produce chlamydospores in cornmeal agar was the common denominator in this group. The strains were categorized into three groups: Group I contained 13 isolates that produced germ tubes but were unable to assimilate trehalose (TRE), glucosamine (GLN) and N-acetylglucosamine (NAG); Group II contained four isolates that were germ-tube positive and able to assimilate TRE, GLN and NAG; and Group III contained eight isolates that were germ-tube negative and able to assimilate TRE, GLN and NAG. These isolates were further studied to determine their biotypes, serotypes, extracellular proteinase production and antifungal susceptibility. Group I isolates were of serotype B, whereas Groups II and III were serotype A. All isolates produced high to moderate amounts of extracellular proteinase. Six group I isolates were resistant to 5-fluorocytosine, whereas all groups II and III isolates were susceptible to this drug. Five of the 12 isolates of group II and III were resistant to fluconazole, itraconazole and ketoconazole.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12146760     DOI: 10.1080/mmy.40.3.301.306

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  9 in total

1.  Cell cycle dynamics and quorum sensing in Candida albicans chlamydospores are distinct from budding and hyphal growth.

Authors:  Stephen W Martin; Lois M Douglas; James B Konopka
Journal:  Eukaryot Cell       Date:  2005-07

2.  Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis.

Authors:  Seyed Amir Yazdanparast; Sadegh Khodavaisy; Hamed Fakhim; Tahereh Shokohi; Iman Haghani; Mojtaba Nabili; Haniyeh Gholami; Imaneh Ahmadi; Hamid Badali
Journal:  Mycopathologia       Date:  2015-07-17       Impact factor: 2.574

3.  Lack of Candida africana and Candida dubliniensis in vaginal Candida albicans isolates in Turkey using HWP1 gene polymorphisms.

Authors:  Ramazan Gumral; Banu Sancak; Ahmet Barış Guzel; Mehmet Ali Saraçlı; Macit Ilkit
Journal:  Mycopathologia       Date:  2011-03-06       Impact factor: 2.574

4.  Candida dubliniensis at a university hospital in Saudi Arabia.

Authors:  R Fotedar; S S A Al-Hedaithy
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

5.  Molecular epidemiology of Candida albicans and its closely related yeasts Candida dubliniensis and Candida africana.

Authors:  Orazio Romeo; Giuseppe Criseo
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

6.  Issues in identifying germ tube positive yeasts by conventional methods.

Authors:  Atta Yazdanpanah; Tzar Mohd Nizam Khaithir
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

7.  Candida albicans ISW2 Regulates Chlamydospore Suspensor Cell Formation and Virulence In Vivo in a Mouse Model of Disseminated Candidiasis.

Authors:  Dhammika H M L P Navarathna; Ruvini U Pathirana; Michail S Lionakis; Kenneth W Nickerson; David D Roberts
Journal:  PLoS One       Date:  2016-10-11       Impact factor: 3.240

8.  Candida species Rewired Hyphae Developmental Programs for Chlamydospore Formation.

Authors:  Bettina Böttcher; Christine Pöllath; Peter Staib; Bernhard Hube; Sascha Brunke
Journal:  Front Microbiol       Date:  2016-10-27       Impact factor: 5.640

9.  Distribution, antifungal susceptibility pattern and intra-Candida albicans species complex prevalence of Candida africana: A systematic review and meta-analysis.

Authors:  Sanaz Aghaei Gharehbolagh; Bahareh Fallah; Alireza Izadi; Zeinab Sadeghi Ardestani; Pooneh Malekifar; Andrew M Borman; Shahram Mahmoudi
Journal:  PLoS One       Date:  2020-08-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.